Trials / Completed
CompletedNCT00406237
Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
Open Label, Single Dose Study Of The Pharmacokinetics Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Open label, single dose study of the pharmacokinetics of tigecycline in adult subjects with primary biliary cirrhosis (PBC)
Detailed description
pharmacokinetic study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tigecycline | Single intravenous dose of tigecycline 50 mg, as a 30-minute infusion |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2006-12-04
- Last updated
- 2011-04-04
Locations
3 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT00406237. Inclusion in this directory is not an endorsement.